NCT01603394 - Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

Postherpetic Neuralgia

Interventions

DRUG

pregabalin

Pregabalin Capsules (150 mg - 600mg), Dose titration (4 weeks) and fixed dose (2 weeks) for a 6 week treatment period.

Trial Locations (9)

Pfizer Investigational Site, Paarl

Pfizer Investigational Site, Jekintown

Pfizer Investigational Site, Schwerin

Pfizer Investigational Site, Raleigh

Pfizer Investigational Site, Leesburg

Pfizer Investigational Site, Lexington

Pfizer Investigational Site, Senftenberg

Pfizer Investigational Site, Vienna

Pfizer Investigational Site, Pretoria